Fatal hyperammonaemia due to late-onset ornithine transcarbamylase deficiency
- PMID: 26819360
Fatal hyperammonaemia due to late-onset ornithine transcarbamylase deficiency
Abstract
In this case report we describe a 67-year-old male, admitted to the ICU with pneumonia who unexpectedly developed a fatal coma due to hyperammonaemia. At postmortem the diagnosis late-onset ornithine transcarbamylase deficiency was made. The non-specific clinical presentation, the rapid deterioration and incidentally the fatal outcome all underline the importance of recognition and knowledge of this genetic disorder. Several measures to treat and prevent potentially fatal episodes of hyperammonaemia are available, if only the disorder is recognised in time. In retrospect, several clues to the diagnosis were available in this fatal case, such as voluntary protein avoidance, as well as several male family members who died at a young age of an unknown cause. After his death, two daughters were discovered to be carriers of an OTC gene mutation, as well as his infant grandson. We emphasise the importance of obtaining ammonia levels in all patients with unexplained coma, seizures or cerebral oedema, irrespective of their age, especially in patients in the ICU or in an otherwise catabolic state.
Similar articles
-
Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report.J Med Case Rep. 2015 Nov 23;9:267. doi: 10.1186/s13256-015-0741-2. J Med Case Rep. 2015. PMID: 26593089 Free PMC article.
-
Valproate-induced fatal acute hyperammonaemia-related encephalopathy in late-onset ornithine transcarbamylase deficiency.BMJ Case Rep. 2021 May 25;14(5):e241429. doi: 10.1136/bcr-2020-241429. BMJ Case Rep. 2021. PMID: 34035022 Free PMC article.
-
[Fulminant coma: think hyperammonemia and urea cycle disorders].Ann Fr Anesth Reanim. 2002 Dec;21(10):820-3. doi: 10.1016/s0750-7658(02)00803-1. Ann Fr Anesth Reanim. 2002. PMID: 12534125 French.
-
Ornithine transcarbamylase deficiency: a urea cycle defect.Eur J Paediatr Neurol. 2003;7(3):115-21. doi: 10.1016/s1090-3798(03)00040-0. Eur J Paediatr Neurol. 2003. PMID: 12788037 Review.
-
[Hyperammonemia type II as an example of urea cycle disorder].Wiad Lek. 2006;59(7-8):512-5. Wiad Lek. 2006. PMID: 17209350 Review. Polish.
Cited by
-
Diagnosis of Inherited Metabolic Disease in Older Patients: A Systematic Literature Review.J Inherit Metab Dis. 2025 May;48(3):e70038. doi: 10.1002/jimd.70038. J Inherit Metab Dis. 2025. PMID: 40406818 Free PMC article. Review.
-
Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.BMC Gastroenterol. 2022 Mar 28;22(1):144. doi: 10.1186/s12876-022-02213-0. BMC Gastroenterol. 2022. PMID: 35346058 Free PMC article.
-
A Mysterious Case of Recurrent Acute Hyperammonemic Encephalopathy.Cureus. 2020 Mar 31;12(3):e7484. doi: 10.7759/cureus.7484. Cureus. 2020. PMID: 32351862 Free PMC article.
-
Management of late onset urea cycle disorders-a remaining challenge for the intensivist?Ann Intensive Care. 2021 Jan 6;11(1):2. doi: 10.1186/s13613-020-00797-y. Ann Intensive Care. 2021. PMID: 33409766 Free PMC article. Review.
-
Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.Case Rep Med. 2016;2016:8512721. doi: 10.1155/2016/8512721. Epub 2016 Sep 21. Case Rep Med. 2016. PMID: 27738433 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical